Keywords: GlaxoSmithKline, OTC brands, Prestige Brands

GlaxoSmithKline divests batch of OTC brands for $660 million, but still more to go

Article | 21 December 2011

Print This

The widely expected sale of UK pharma giant GlaxoSmithKline (LSE: GSK) non-prescription brands was confirmed this week when US consumer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in